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Abstract
Background: Antenatal care (ANC), facility delivery and postnatal care (PNC) are proven to reduce maternal and child
mortality and morbidity in high-burden settings. However, few pregnant rural women use these services sufficiently. This
study aims to assess the impact, cost-effectiveness and scalability of conditional cash transfers to promote increased
contact between pregnant women or women who have recently given birth and the formal healthcare system in Kenya.
Methods: The intervention tested is a conditional cash transfer to women for ANC health visits, a facility birth and PNC
visits until their newborn baby reaches 1 year of age. The study is a cluster randomized controlled trial in Siaya County,
Kenya. The trial clusters are 48 randomly selected public primary health facilities, 24 of which are in the intervention arm
of the study and 24 in the control arm. The unit of randomization is the health facility. A target sample of 7200 study
participants comprises pregnant women identified and recruited at their first ANC visit over a 12-month recruitment period
and their subsequent newborns. All pregnant women attending one of the selected trial facilities for their first ANC visit
during the recruitment period are eligible for the trial and invited to participate. Enrolled mothers are followed up at all
health visits during their pregnancy, at facility delivery and for a number of visits after delivery. They are also contacted at
three additional time points after enrolling in the study: 5–10days after enrolment, 6 months after the expected delivery
date and 12 27 months after birth. If they have not delivered in a facility, there is an additional follow-up 2 wees after the
expected due date. The impact of the conditional cash transfers on maternal healthcare services and utilization will be
measured by the trial’s primary outcomes: the proportion of all eligible ANC visits made during pregnancy, delivery at a
health facility, the proportion of all eligible PNC visits attended, the proportion of referrals attended during the pregnancy
and the postnatal period, and the proportion of eligible child immunization appointments attended. Secondary outcomes
include; health screening and infection control, live birth, maternal and child survival 48 h after delivery, exclusive
breastfeeding, post-partum contraceptive use and maternal and newborn morbidity. Data sources for the measurement
of outcomes include routine health records, an electronic card-reader system and telephone surveys and focus group
discussions. A full economic evaluation will be conducted to assess the cost of delivery and cost effectiveness of the
intervention and the benefit incidence and equity impact of trial activities and outcomes.
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Discussion: This trial will contribute to evidence on the effectiveness and cost-effectiveness of conditional cash transfers
in facilitating health visits and promoting maternal and child health in rural Kenya and in other comparable contexts.
Trial registration: ClinicalTrials.gov, NCT03021070. Registered on 13 January 2017.
Keywords: Conditional cash transfers, Maternal and child health, Antenatal care, Facility delivery, Postnatal care, Child
immunization, Cluster randomized controlled trial, Kenya
Background
A “Continuum of Care” for reproductive, maternal, new-
born and child health (RMNCH) includes integrated
service delivery for mothers and children from pre-preg-
nancy to delivery, the immediate postnatal period and
early childhood [1]. Assuring continuity of care has
become a key programme strategy for improving the
health of mothers and newborns, and is an important
measure of service quality for outcomes such as preven-
tion of mother-to-child transmission of HIV (PMTCT)
[2]. Yet, in many countries, there remain major gaps in
seeking care along this continuum. Retaining women in
this continuum even during pregnancy has not yet been
achieved in sub-Saharan Africa (SSA), with only 44% of
women attending the minimum of four recommended
visits that constitute focused antenatal care (ANC) [3].
Focused ANC is a scheduled service, and when clients
do not adhere to the recommended timing or frequency,
the effectiveness of the service is compromised. A num-
ber of complementary treatments provided during ANC
have to be delivered in sequence for them to be effective.
Examples include iron and folic acid supplementation, tet-
anus toxoid immunization, syphilis testing and treatment,
counselling on maternal and infant nutrition and intermit-
tent preventive treatment of malaria in pregnancy (IPTp)
[4]. Postnatal services are equally essential, as half of all
postnatal maternal deaths occur during the first week after
delivery, and one in four child deaths occur in the first
month of life [5]. In SSA, postnatal care programmes are
among the weakest of all reproductive and child health
programmes [6]. Follow-up treatment and services such as
PMTCT, family planning, breastfeeding and infant feed-
ing support and childhood immunization cannot be
achieved if women are lost to care immediately after
delivery, as is the current trend.
Complex structural, financial, cultural and behavioural
factors contribute to gaps in care seeking in SSA [7, 8].
In Kenya, where maternal mortality rates are 488 per
100,000 live births, a lack of transport has been cited as
one of the major contributing factors to low utilization
of healthcare services [9]. In a national survey [9], the
largest proportion of respondents (42%) reported that
delivering outside a health facility took place because the
facility was far away or they lacked transport to the
facility. In comparison, only 17% cited the fees levied at
the facilities as the key barrier [9]. Other barriers include
the indirect costs of care seeking such as food for
mothers and accompanying children, new clothes appro-
priate to be seen at ANC visits, and the opportunity cost
of time away from farming or other income-generating
activities [10]. Cultural barriers have also been reported.
In Zimbabwe, Chapman [11] found that because women
have high maternal morbidity and miscarriages in their
communities, and at the same time are under high social
pressure to bear children, they hide their pregnancies to
protect themselves and the unborn child from witchcraft
and sorcery. Lack of knowledge about the benefits of
care seeking is yet another important barrier [10]. One
study in Kenya showed that the motivation to attend
ANC was driven by authority-linked factors, such as
obtaining an ANC card to avoid reprimand or reduced
care by the staff during birth [10]. The visits are there-
fore made late in pregnancy, and discontinued once the
ANC card is obtained. In the light of these multiple
challenges, an intervention targeted at only one of the
barriers (e.g. removal of user fees, or provision of trans-
port vouchers) will only have a limited impact.
Personal financial incentives (PFIs) may offer the
broad-based solution needed to tackle low levels of care
seeking and retention of women in the care continuum.
PFIs can tackle both the financial barriers to care seeking
and the motivational barriers. Several studies [12–15] have
demonstrated how personal financial incentives (PFIs) can
help to increase adherence to lengthy treatment schedules.
In developed countries, paying people to change their be-
haviour has been effective in reducing excess consumption
of high-fat foods, cigarettes, alcohol and illicit drugs [16].
Notable successes in developing countries include tuber-
culosis (TB) treatment programmes, where financial and
material incentives directed to patients increased success-
ful completion of TB treatment regimens [17, 18]. Outside
the context of TB, PFI schemes in SSA remain largely un-
tested. In the context of reproductive, maternal, neonatal
and child health, few cash transfer programmes have been
piloted, and none have targeted adherence to a scheduled
programme or treatment schedule; instead the focus has
been on a specific aspect of the care system such as ANC
attendance or facility delivery [19, 20].
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There is an opportunity to test the effectiveness of PFI
as a broad-based intervention to improve maternal
care-seeking behavior in the Kenyan context. Over two
thirds of women come into contact with the formal
healthcare system at least once during pregnancy [3]. A
strategy that can retain these women in care, from their
first contact in pregnancy through to delivery and the
childhood period, could significantly alter the negative
trends in maternal and child health in this context and
possibly also in Africa more generally.
This trial is testing the effectiveness and cost-effective-
ness of cash incentives in retaining women in the con-
tinuum of care from their first ANC visit until their
children reach 1 year of age. It will be the first trial in
SSA targeted at retaining women in the maternal, new-
born and child health (MNCH) care continuum, and will
generate crucial evidence to inform policy and practice.
A secondary aim of the project is to assess the benefits
of improved care-seeking in maternal and child health,
and the cost-effectiveness of the intervention.
Methods
Study setting
The study is conducted in Siaya County, Kenya, located
on the shores of Lake Victoria, in the West of the coun-
try. Siaya County has a population of 984,069 people
and is made up of six sub-counties, which are mostly
rural and perform poorly on several development and
health indicators [21]. As a whole, the County has a hu-
man development index (HDI) score of 0.46, signifi-
cantly below the national average of 0.56 [22]. It has the
highest national rates of HIV infection, TB and malaria
in Kenya, and among the worst indicators of child and
overall health status [23]. Infant mortality stands at 111
per 1000 live births against 49/1000 for the country, and
maternal mortality at 695 per 100,000 live births against
488/100,000 in Kenya. On a few indicators, the County
performs better than the national average. For instance,
38% of the population in Siaya live below the poverty
line, while the country’s average is 45% [24]. The rate of
immunization in children under 1 year is 72.5% against
67.5% for the country, and the rate of delivery by a skilled
attendant is 69.6% against a 61.2% national average [23].
In 2015, Siaya County had 174 health facilities with
123 categorized as public, 7 as non-governmental, 16 as
faith-based and 28 as private [25]. Health facilities in
Kenya are graded into 6 levels. Level 1 facilities are
found at the community level, facilitate community diag-
nosis, management and referral to upper facility levels
and encourage appropriate healthy behaviours. Level 2
facilities, known as Dispensaries, are the interface between
the community and the health system, and offer basic
curative, case management, prevention and promotion
services and basic ANC. Level 3 Health Centres offer
curative and case management services for infectious and
chronic illnesses and inpatient care, and may cover a
catchment of 10,000 people or more. Level 4 facilities are
sub-County Hospitals that serve as secondary care faci-
lities but also offer primary healthcare services such as
ANC. Level 5 facilities are County Referral Hospitals and
offer a broader spectrum of specialized services. Finally,
the level 6 facility is a National Referral Hospital, Kenyatta
Hospital in Nairobi [26]. The health facilities in Siaya
County include one level 5 hospital and one level 4 facility
in each sub-County [27]. The rest are mainly level 3
Health Centres and level 2 Dispensaries staffed by nurses
or clinical officers, and level 1 community facilities staffed
by community health volunteers (CHVs). Overall, there is
low coverage of healthcare in the County, with a
physician-to-population ratio of 1: 62,000, and nurse-to-
population ratio of 1: 2500 [25].
The implementing project partner, Safe Water and
AIDS Project (SWAP- http://www.swapkenya.org/), has
been working in the region since 2005 to improve ma-
ternal and child health. Their work has focused on level
1 services, which are aimed at empowering Kenyan house-
holds and communities to take charge of improving their
own health, and fall within the Kenya Essential Package
for Health (KEPH) Community Strategy. They work in
close collaboration with the Ministry of Health and Siaya
County Government. Despite these and several other
governmental, non-governmental organization (NGO)
and donor funded efforts at community level, there still
remains a wide gap in reaching pregnant women with the
essential package of services that formal healthcare faci-
lities would routinely deliver to those retained in the
continuum of care.
Trial design
The study is a cluster randomized controlled trial (cRCT)
in which 24 clusters are randomized to receive the inter-
vention and 24 clusters are randomized to the control.
Cluster size and selection
Level 2 or 3 health facilities are the units of
randomization. Level 2 or 3 facilities are comparable
and comprise Dispensaries and Health Centres, re-
spectively. While there may be some difference in the
services provided at these facilities, only those offering
the full profile of antenatal services were considered
for inclusion in the study. All eligible clients attending
participating facilities during the enrolment period
were recruited into the trial, subject to consent. Based
on the background data on ANC attendance in the
study region, it is expected that each of the 48 clusters
will recruit 150 participants into the trial, giving a
total sample of 7200 eligible women.
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Randomization
A master list of 84 eligible level 2 and 3 health facilities in
Siaya County was generated in December 2016. The mas-
ter list was stratified by sub-County, so that selection onto
the master list was proportional to the number of facilities
in each sub-County. From the stratified master list, a
short-list of 60 facilities was randomly selected for poten-
tial inclusion in the study. The random selection of the 60
short-listed facilities was thus also stratified by sub-
County, with the shortlist in each sub-County propor-
tional to the number of eligible health facilities on the
master list for that sub-County. Facilities were selected so
that catchment areas did not overlap.
In January 2017, the 60 shortlisted facilities were re-
duced to a final sample of 48 facilities for inclusion in
the trial, 24 in the intervention and 24 in the control
arm. The selection of the 48 final facilities included in
the trial, and their allocation to intervention or control,
took place in a public forum to ensure that the selection
and allocation processes were transparent and acceptable
to senior management in the County Government. To
achieve this level of transparency in the selection
process, a public meeting was organized. The County
Director and the Medical officer of health (MoH) in
charge of each of the six sub-counties in Siaya were in-
vited to attend the meeting and participate in the health
facility selection and mapping. Each MoH was asked to
bring along the County Records Officer (CRO) and
another member of their sub-County Health Manage-
ment Team (CHMT).
During this meeting, the names of all 60 short-listed
facilities were written on individual pieces of paper,
folded and placed into six transparent plastic boxes -
one for each sub-County. The total target sample of 48
facilities was divided between sub-Counties broadly in
proportion to the number of facilities in the master list,
but with rounding so that each sub-County had an even
number of facilities in the trial. The Health Management
Teams from each sub-County were invited in turn to se-
lect a piece of paper from their respective box, beginning
with the Northernmost sub-County. The first facility se-
lected was allocated to the intervention arm and the sec-
ond to the control arm, the third to intervention and so
on in succession. The name of each selected facility was
written on a board, together with the allocation. For
each selected facility, the records officer for the sub-
county was asked to map the location and catchment
area on a large map of the county. If a subsequently
selected facility was found to have an overlapping catch-
ment area with a facility previously selected, then the
newly selected facility was rejected and another drawn
from the box to take its place. This process continued
until 48 facilities had been selected and allocated for the
trial. This meeting generated a list of 24 intervention and
24 control facilities, with their location and catchment areas
mapped to ensure that they do not overlap. In summary,
the randomization is stratified by sub-County and ensures
equal allocation to study arms within each stratum.
Trial participants
Eligible participants are women attending their first
ANC visit in public primary healthcare facilities in the
study area. The ANC attendance rate for at least one
visit is very high in Kenya, and more than 80% in Siaya
County [10]. The majority of visits take place at level 2
Public Dispensaries and level 3 Health Centers, where
the government has abolished user fees for maternal
care since June 2014 [28]. Participant recruitment will
not be conducted in private clinics, which levy user fees
and are more likely to be visited by a small number of
women of higher socio-economic status. Participants
will also not be recruited from level 4 or 5 facilities, as
this would bias the sample towards more complicated
pregnancies or serious health conditions.
Trained and incentivized health staff determine if a
pregnant woman meets the study eligibility criteria by
administering screening questions at the end of her
ANC visit. Criteria for enrolment are:
i. Women attending their first ANC visit;
ii. Long-term resident of the catchment area served by
the health facility, with long-term residence defined
as living in the area for at least 6 months; and
iii. Women with access to a mobile phone that belongs
either to themselves or to a member of their
household or person whom they trust. Access to a
mobile phone is a project requirement for the cash
transfer payments and participant follow up. This
requirement was easily met by all women (n = 200)
during the pilot phase of this project.
If a woman is eligible, the recruiting staff explain the
objectives of the study and seek her consent to
participate.
Enrolment into the study commenced in June 2017
(Fig. 1) and is ongoing. Initially, the enrolment duration
was estimated to be 9 months, with an estimated 816
pregnant women recruited into the study each month,
leading to a total sample of 7200 women. However, a
nationwide health workers’ strike began in June 2017
shortly after initiation of the study and continued until
November 2017. During this period, 18 health facilities
continued to provide health services with the support of
NGOs, and were able to enrol participants. The
remaining 30 health facilities were not operational and
only started to enrol participants in November 2017
after the strike had been resolved. As of February 2018,
the project has enrolled 2841 pregnant women. At the
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time of writing, enrolment is expected to proceed until
July 2018 or until the sample size of 7200 is reached.
Once enrolled into the study, the participant is followed
341 up until the expected baby is 1 year of age (Additional
file 1). Participants who move out of the study location
are considered lost to follow up.
Intervention strategy
Cash transfer value
The intervention is a conditional cash transfer (CCT) pay-
ment for each facility appointment attended for ANC,
delivery, postnatal care and childhood immunization; and
referrals related to any of these visits. For each verified
health visit that is made on time following enrolment, a
woman receives a cash transfer of Ksh 450 (4.5 USD). The
value reduces by one quarter for each week of delayed
visit, and no reward is offered for any visit made 3 weeks
after the appointment date. On average, Ksh 450 equates
to the transportation cost of a local taxi to the health facil-
ity, and is a value that has been approved by the research
ethics committee for many studies in the region as reason-
able compensation for research participants.
Card-reader system for automatic tracking of health visits
and cash transfers
Afya card Once consent to participate in the trial is ob-
tained, all women recruited into the study are given an
ANC clinic book as is standard practice. Additionally,
they are provided with a special enrolment card (Afya
card) that contains their study ID and that is linked to a
card reader terminal installed at all participating health
facilities. The card is attached to the clinic book so that
participants do not leave it behind when making the
health visits.
The Afya card is the size of a credit card and stores
holder data. These include authentication information
(study ID, study arm, clinic at which enrolled), pregnancy-
related information (pregnancy stage at enrolment, ex-
pected delivery date (EDD), parity) and information on
health visits made (where and when) throughout the study
Fig. 1 Schedule of enrolment, interventions and assessments. *MNCH appointments/visits – Standard maternal and child health visits described
in Additional file 1. **Covariates - see Table 1. ***Health outcomes - see Additional file 2. MNCH, maternal, newborn and child health; ANC,
antenatal care; PNC, postnatal care
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period. The background and pregnancy-related informa-
tion is collected at enrolment by a nurse at the clinic, who
then loads it onto the card upon touching the card to the
reader. The nurse also keys in the date of enrolment and
the date of the next visit, which gets loaded onto the card
upon touching the reader. Subsequent health visits by par-
ticipants are recorded in their clinic books and the clinic
records as is standard practice (Additional file 2). Add-
itionally, the visits are automatically tracked by touching
the card on the card reader. At the end of each visit, the
nurse keys into the reader the date of the next health visit,
to enable automatic tracking of whether the visit is
attended and how timely the visit was.
Card reader Card readers are installed in all participat-
ing intervention and control facilities. The device used is
a Famoco Fx100, an android near field communication
(NFC) card reader. The Fx100 has an in-built SIM card
slot and is enabled for GSM/GPRS/3G communication.
The card reader is connected to a remote server that
electronically personalizes the NFC card of the user dur-
ing enrolment, and tracks her subsequent health visits.
Each time the Afya card makes contact with the reader,
the information stored on the card is transmitted to the
reader and from the reader to the card, then subsequently
from the reader to the web portal (an electronic database)
[29]. The card also has an offline transacting capability
with the terminal reader that enables it to function during
occasional absence of connectivity. The reader also comes
with a power back up that enables it to function when
there is no electricity for a prolonged duration.
This web portal enables the study team to remotely
track participants’ health facility attendance through-
out pregnancy and up until 12 months after delivery,
and to effect the cash transfer payments. On confirm-
ation of a timely visit, payments to participants are
made directly from the project’s bank account where
the funds are held, to the participants’ mobile money
accounts. This is achieved through integration of the
Famaco FX card reader system with Safaricom Bulk
Disbursement Service, the leading mobile money pay-
ment provider in Kenya. A payout is thus automatic-
ally triggered following the touching of the Afya card
on any of the 48 terminal readers. Manual payouts
are triggered by the project team upon verification of
visits by participants who forget to carry their clinic
books during the visits or who visit non-enrolling fa-
cilities that have no readers installed. Pregnant
women are therefore not restricted to using the facil-
ity at which they were enrolled as long as it is within
the study evaluation zone, which is Siaya County.
Health visits outside Siaya County are not recorded
or rewarded, except for high-risk groups (see Collect-
ing data on visits to facilities outside the study area).
The web portal is continually monitored by a member
of the project team to ensure that there are no pending
payments for timely health visits attended. The project
team also makes regular visits to the health facilities to
monitor whether all system components function as ex-
pected, and to resolve any challenges promptly.
Gratuity for control group participants
Although the primary function of the cash transfer is to
motivate health facility visits, the cash payment could
additionally motivate women in the intervention group
to carry their ANC clinic books when they visit the
clinics. This is because the Afya card embedded in the
book facilitates automated payment transfers to the
women at the end of the clinic visit. Forgetting to carry
the ANC clinic card during ANC visits delays the pay-
ment as the visit must be verified manually. Therefore,
to balance out the possible health effects of carrying the
ANC clinic book in the intervention and control groups,
a nominal gratuity for carrying the clinic book is offered
to women in the control group, who might have lower
motivation to carry the book. The gratuity is in the form
of mobile phone airtime with a value of Ksh 50 (0.5
USD) for every eligible visit, transferred through the
same system that is used to issue the incentives. Ksh.50
is approximately equivalent to the cost of five bananas
purchased at a market and would not compensate par-
ticipants for the cost of attending the health visit. It may
however, be an incentive for a woman who was going to
go to the clinic anyway, to carry her clinic book.
Participants in both study groups are followed up in
the same way, including monitoring of visits using the
electronic-based system and telephone surveys con-
ducted at key points in the care continuum. Follow up is
described Data collection methods.
Health staff incentives
Trained and incentivized health staff determine if a
pregnant woman meets the study eligibility criteria by
administering screening questions at the end of her
ANC visit. Health staff also collect background infor-
mation on participants and key it into the card reader.
During subsequent visits, staff key in the next visit
dates on the readers to enable electronic tracking of
whether the visit was attended and when it was
attended. This determines the amount of cash incentive
the participant receives. Staff are paid 400 Ksh (about 4
USD) per person enrolled into the trial, to recognize
their time and effort in enrolling participants and track-
ing subsequent health visits.
Theory of change
The intervention’s theory of change [30] is described
in Fig. 2 and is informed by the World Health
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Organization (WHO) guidelines for health visit sched-
ules for women during pregnancy, birth and the post-
natal period [4]. Extensive evidence supports the
health benefits of services offered during these visits
[4] (Additional file 4).
The rationale for the use of a CCT intervention is
found in behavioural economic theory, which suggests
that individuals commonly have inconsistent preferences
for similar outcomes occurring at different points in the
future, with outcomes in the near future generally valued
more than those in the distant future [31, 32]. According
to Giles et al. [33], while the health gains of health-pro-
moting behaviours are often delayed in time, the
financial and opportunity costs are usually immediate.
Individuals thus make a rational choice to pursue
unhealthy behaviours or delay spending on health-pro-
moting activities in the present but with future benefits.
Cash transfers work by bringing long-term goals into the
short-term decision horizon by providing immediate re-
wards and reducing current costs [33].
This study is based on the theory that cash trans-
fers overcome direct and indirect financial and behav-
ioural barriers to healthcare attendance during
pregnancy, delivery and the postnatal period, and in
so doing would lead to more regular use of services
compared to current practice. Retention of women in
the care continuum from pregnancy through the post-
natal period will have a positive impact for MNCH
interventions that require regular treatment and fol-
low up.
Research questions
This study aims to investigate whether CCTs are ef-
fective in retaining women in the continuum of care
for MNCH. The secondary objectives of the study aim
to establish whether regular care-seeking within the
MNCH continuum, incentivized by the CCTs, leads to
improved maternal and child health outcomes and
whether it can be cost-effective. To answer these
Fig. 2 Theory of change. MNCH, maternal, newborn and child health; ANC, antenatal care; PNC, postnatal care; EBF, Exclusively breastfeeding
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questions, a number of primary and secondary out-
comes will be measured.
Primary outcomes
The following primary outcomes will be measured and
compared between the two study arms:
1. The proportion of eligible ANC visits made after
recruitment
2. The proportion of participants delivering babies at a
health facility
3. The proportion of eligible health appointments
attended for PNC
4. The proportion of expected immunization
appointments attended by children
5. The proportion of health referrals attended for
ANC, PNC and child immunization
Secondary outcomes
The secondary outcomes are:
1. Proportion of women retained in the continuum of
MNCH from pregnancy to 12 months post-delivery
2. Likelihood of a live birth and child survival 48 h
after birth
3. Likelihood of maternal death during delivery and 48
h postpartum
4. Self-rated health of mothers at 6 months and 12
months after delivery
5. Mother’s perception of infant’s health 6 months and
12months after delivery
6. Proportion of mothers exclusively breastfeeding to
6 months of age
7. Proportion of women using family planning or
contraceptives after delivery
8. Screening and control of infections for mothers and
fetus/baby during pregnancy and postnatal periods
9. Cost of delivery and cost effectiveness of the
intervention
10. Benefit incidence and equity impact of the
intervention
Process evaluation [34] will document the design, im-
plementation and mechanisms of the intervention. A full
economic evaluation will be conducted to assess the cost
of delivery and cost effectiveness of the intervention and
the benefit incidence and equity impact of trial activities
and outcomes.
Sample size
We hope to analyse all the primary outcomes jointly and
also to analyse most outcomes as ordinal variables (see
Data management and analysis), thereby maximising
power and aiding interpretation. However, for our
sample size calculation, we consider power to detect an
effect of the intervention on one primary outcome,
which we also assume to be a binary indicator that all at-
tendances are made, as this is simple and conservative in
the power achieved. The expected prevalence of these
indicators in the control arm ranges between 30 and
80%. Little specific information on the likely intra cluster
correlation (ICC) for any of the outcomes is currently
available - we consider it may lie between 0.005 (low)
and 0.025 (moderate). Our planned sample size is 48
clusters (24 per arm) and an average cluster size of 150.
At a low ICC, the design effect (DE) will be 1.745 and
hence the effective sample size (ESS) will be 2063 partic-
ipants per study arm. At a moderate ICC, the DE will be
4.725 and hence the ESS will be 762 per arm. Power to
detect absolute differences is lowest when the prevalence
is 50% and highest when the prevalence is either high
(towards 100%) or low (towards 0%). Here we consider
the prevalence in the control arm to range between 50%
(‘worst-case scenario’) and 80% (‘best-case scenario’). We
consider the standard 5% significance level. If the preva-
lence of the outcome is 50% in the control arm, the sam-
ple size provides 80% power to detect an improvement
to 54.5% in the intervention arm if the ICC is low and
57.5% if the ICC is moderate. If the prevalence of the
outcome is 80% in the control arm, the sample size pro-
vides 80% power to detect an improvement to 83.5% if
the ICC is low and 85.5% if the ICC is moderate.
Data collection methods
Data are collected in person by nurses at enrolment,
over the telephone by trained interviewers at key time
points, and through manual extraction of routine health
records supplemented by the electronic contact card sys-
tem. Data are also collected to facilitate rigorous process
and economic evaluations. Table 1 summarizes the data
collected using each method.
Data collection at enrolment
During enrolment, after written informed consent has
been obtained, a trained nurse at the enrolling facility
extracts background information from the participant’s
health records and enters them into the card reader as
described in section Card-reader system for automatic
tracking of health visits and cash transfers. The extracted
data include name, age, marital status, parity, stage of
pregnancy, expected date of delivery (EDD), area of resi-
dence and mobile phone number.
Telephone surveys
Data are collected on secondary outcomes, socio-economic
characteristics, care seeking and decision-making regarding
the cash transfer, using the four follow-up telephone sur-
veys described subsequently. Some data on the primary
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outcomes are also collected (see Table 1). The surveys are
administered to all participants in both the intervention
and control groups.
Telephone survey one: after enrolment
The first telephone interview is conducted with all par-
ticipants as soon as possible after enrolment. This struc-
tured questionnaire collects data on socio-economic
status, self-rated health and decision-making. Information
on the recent health visit is also collected, including cost
and time taken to travel to the facility, waiting time, cost
of all care received and satisfaction with the care received.
The same questionnaire is administered to the interven-
tion and control groups, and the interviewer is blinded to
the allocation of the participant.
Telephone survey two: 2 weeks after the EDD, if no
facility delivery
Table 1 Primary and secondary outcomes of the trial and sources of these data for different outcomes
Primary outcomes Source of data
• Proportion of all eligible ANC visits made after recruitment
• Delivery at a health facility
• The proportion of health appointments honoured for PNC at
week 2 to 6 after delivery, and months 4–12 after delivery
• Proportion of referrals for ANC, PNC and child immunization attended
Proportions of immunization appointments attended by children
• Abstracted health records from the health facility
• Electronic system used to enrol participants into the study
• Telephone surveys will collect visits made outside the study area by all
“high risk” women and 50% of other women
Secondary outcomes Source of data
• Proportion of women retained in the continuum of MNCH from
pregnancy to 12 months post-delivery
• Clinic records
• Electronic card system
• Telephone survey 3 at 6 months after delivery
• Likelihood of a live birth and child survival 48 h after birth • Clinic records
• Telephone survey 2 at 2 weeks after EDD, if not delivered at the facility
• Likelihood of a maternal death during delivery and 48 h postpartum • Clinic records
• Telephone survey 2, 2 weeks after EDD, if not delivered at the facility
• Self-rated health of mothers, 6 months and 12months after delivery • Telephone surveys 1, 3 and 4 at 6 months and 12months after delivery
• Mother’s perception of infant’s health, 6 months and 12 months after
delivery
• Telephone surveys 2, 3 and 4 at 6 months and 12months after delivery
• Proportion of mothers exclusively breastfeeding to 6 months of age • Telephone surveys 2 and 3 and 4 at 6 months and 12 months after delivery
• Proportion of women using family planning and contraceptive use
after delivery
• Telephone surveys #3 and #4 at 6 months and 12 months after delivery
• Screening and control of infections for mothers and fetus/baby
during pregnancy and postnatal periods
• Clinic records (ANC, HF deliveries and PNC clinic records)
• Manual collection of health records
• Cost of delivery and cost effectiveness of the intervention • Project accounts
• Key informant interviews
• Facility costing tool
• Benefit incidence and equity impact of the intervention • Clinic records
• Electronic system
• Telephone surveys 1, 2, 3, 4
Key confounders/covariates Source of data




• Distance to facility
• Level of health facility
• Marital status
• Number of children
• Planned pregnancy
• Quality of care (e.g. waiting time)
• Migration away from study area
• Enrolment survey at health facility
• Clinic records
• Telephone survey 1, 3, 4
Key process indicators Source of data
• Satisfaction with care received • Telephone surveys 1, 2 and 3 at 2 weeks, 6 months and 12 months after
delivery, focus group discussions with a sub-sample of participating
women in the intervention area
• Health worker motivation • Key informant interviews with health service providers
• Receipt of the Afya and/or any other transfers • Telephone surveys 3 and 4 at 6 months and 12 months after delivery
MNCH maternal, newborn and child health, ANC antenatal care, PNC postnatal care, EDD expected delivery date
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A phone survey is conducted with all mothers who de-
livered babies at home, 2 weeks after their EDD. This
survey collects information on delivery date, delivery
outcome, who conducted the delivery, self-rated wellness
for mother and child and breastfeeding initiation. The
interviewer is blind to participant allocation.
Telephone survey three: 6 months after the EDD/child
birth
A telephone survey is administered to 50% of parti-
cipants 6 months after the EDD, to collect data on
secondary outcomes such as maternal and child deaths,
self-rated health of mothers and infants, exclusive
breastfeeding and utilization of family planning
methods. This survey also collects information on the
last health care visit including the cost of seeking care,
purpose of visit, waiting time and visit experience.
A second part of the survey is used to elicit informa-
tion on the receipt of any conditional or unconditional
cash transfer, receipt of Afya transfers (in the interven-
tion arm only), how any money received was spent and
who decided how the money was spent. The inter-
viewer is not blind to participant allocation, as some
questions are related to receipt and utilization of the
cash transfers.
Telephone survey four: 12 months after the actual
delivery date
A final survey is conducted with the same 50% of
participants who completed telephone survey three.
This survey again collects data on secondary out-
comes such as maternal and child deaths, self-rated
health, breastfeeding and utilization of family planning
methods, information on the latest health care visit,
and receipt and use of any cash transfers. Moreover,
this survey collects additional information on comple-
mentary feeding and immunization. The interviewer is
blind to participant allocation except for the final part
that seeks information on receipt of cash transfers
and its usage.
Manual extraction of health records
At the end of the enrolment period and throughout the
remaining trial period, health seeking and health status
data will be manually extracted from routine health
records held at facilities. Additional file 2 shows the de-
tailed health records that are taken during ANC,
delivery and postnatal health visits. A record book is also
available at health facilities for each child, and a child
growth card is issued to women who deliver at health
facilities. This card contains key data on the newborn
from birth until they reach 5 years of age.
Towards the end of the trial period, data on health
visits and services will also be collected from referral
facilities attended by the participants. Data on visits
made to health facilities outside Siaya County will not be
extracted or rewarded. Participants will be identified in
the records by their study ID number1 to ensure partici-
pant confidentiality.
Electronic capture of health visits
A secondary method for collecting data on the primary
health outcomes is the electronic card reading system as
described previously (see “Card reader”). The system has
been designed for the project by an information and
communications technology (ICT) company in Kenya
called Nailab. The system is fully owned by the project
and will only be utilized to fulfill the objectives of the
project. Using two primary data collection methods will
enable us to triangulate our data and increase confi-
dence in the trial results.
Collecting data on visits to facilities outside the study area
The strategies used to collect these data vary according
to whether or not the participant is considered high risk.
High-risk groups in this study comprise mothers whose
ANC records show HIV-positive status, positive malaria
smear test and/or other diagnoses of sexually transmit-
ted infection (STI). These diagnoses are likely to require
referrals and additional health visits not captured in rou-
tine ANC or PNC records. Furthermore, participants
with these complications are more likely to be lost to
the routine monitoring systems as they might completely
shift their ANC, delivery and PNC visits to the referral
centers that handle these infections.
We will track all health visits made by high-risk partic-
ipants only, including those taking place in neighbouring
counties outside the evaluation zone. This would be
done through extra phone calls to the participants to
elicit information on health facilities visited. The study
team will then visit those facilities and manually extract
health records as described previously. The exception to
this case would be if care is sought outside the Western
Kenya region, in which case the data will be considered
missing in the case of a single instance of care seeking,
or the participant will be classed as lost to follow up if
they have permanently transferred.
For lower risk participants, we shall incorporate ques-
tions relating to the primary outcomes (facility visits,
child vaccinations etc.) into the telephone surveys (see
Telephone surveys) administered to 50% of participants.
This gives participants the opportunity to report visits
both outside the study area and within, and we shall also
ask whether the participant moved temporarily or per-
manently outside the study area. By comparing these
self-reports with the data on visits within the study area
(collected by other means) we will be able to approxi-
mately deduce the number of visits made outside the
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study area. These additional visits will not be verified by
the study team as will be done for high-risk participants.
Baseline data
In order to understand the baseline characteristics and
behaviour of the sample population, a retrospective audit
of ANC, delivery and PNC will be undertaken by chart
review at selected facilities. The retrospective chart audit
entails collection of data from all facilities, between
January and December 2016 in the year preceding the
commencement of participant enrolment. The data were
collected according to a pre-determined proforma. This
included data on primary trial outcomes, retention at
the local facility and continuity of care. Data were ano-
nymised at collection and each new entry was assigned a
unique retrospective Afya identifier number.
Process evaluation
To inform replication and scale up of the intervention, a
mixed method process evaluation is underway to docu-
ment the design, implementation and mechanisms of
the intervention. The process evaluation is aimed at an-
swering the following questions:
1. What factors affect the intervention’s delivery and
impact?
2. What are the likely operational requirements for
delivering the intervention at scale?
3. How acceptable is the intervention to recipients?
4. What is the impact of the intervention on health
staff motivation and job satisfaction?
Quantitative data for the process evaluation are being
collected from health records, telephone survey data and
Afya contact-card data as described previously for the
main trial outcomes. Qualitative data for the process
evaluation are being collected via key informant inter-
views with a sub-sample of participating health facility
staff, focus group discussions with a sub-sample of par-
ticipating women in the study area, with sampling to sat-
uration and field notes from intervention team members
and notes from the monthly debriefing meeting.
It is also expected that the intervention will increase
demand for health services. However, no expansion in
health service supply is planned and as such, the in-
crease in demand will likely increase the workload of
existing staff. To capture any unanticipated impact on
effort, data on health workers’ motivation and satisfac-
tion [35] will be collected in both arms of the trial. A
less motivated health worker may perform adequately in
minimally demanding conditions, but their willingness
to exert extra effort might depend on whether they feel
there is personal value in doing so [36]. Further, if a
workplace is not conducive to effective working, or if
health workers do not have the knowledge, skills or
experience to complete their tasks, they might be demo-
tivated. Thus, health worker motivation is the ability and
willingness to put in the effort required to do the job, in-
fluenced by individual factors (such as knowledge, skills,
experiences, psychological attributes) and organisational
factors (such as physical and social environment, policies
and practices) [37]. Organisational factors are more
likely to change than individual personality tendencies,
or societal and cultural values. Thus, with the introduc-
tion of the card system and the potential increase in the
demand for MNCH services, health worker motivation
is likely to be affected, with consequences for service
delivery. A self-completion motivation and job satisfac-
tion survey will thus be administered to all participating
health staff. Collecting and analysing these data will
allow us to explore how the intervention could affect
health worker motivation and satisfaction [38], and
potentially service delivery.
Economic evaluation
An economic evaluation will be conducted from the pro-
vider perspective. Costs incurred by implementing agen-
cies will be collected prospectively from the project
accounts and input into a customised Excel-based costing
tool. Data on healthcare provider costs will be collected
retrospectively from a random sample of participating
health facilities in the control and intervention arms. Data
on resource use for maternal and child services, including
equipment, drugs, floor space, overheads and the time
input of health facility staff, will be collected using key in-
formant interviews with healthcare providers and financial
controllers [39–41]. These data will be supplemented with
information on participants’ health-seeking behaviour and
utilization, collected through the card reader and follow-
up phone surveys.
All costs will be adjusted for inflation using the Kenyan
Consumer Price Index (CPI) and presented in inter-
national dollars. The incremental cost-effectiveness of the
Afya intervention will be compared with the status quo al-
ternative. Incremental cost-effectiveness ratios (ICERs)
will be calculated for all statistically significant primary
trial outcomes, as well as selected significant secondary
outcomes. In addition to ICERs, results will be presented
as a cost-consequence analysis [42, 43], listing all costs
and outcomes separately, allowing policymakers to com-
pare the costs and impacts of the Afya intervention.
Data management and analysis
Blinding
Due to the nature of the intervention, participants are
not blinded to their study allocation. Some data collec-
tion is, however, blinded to the intervention allocation
status of participants as described in the data collection
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section. Project managers are not blinded to the alloca-
tion status of the study participants; however, the Princi-
pal Investigators and analysts will remain blinded. Data
will be analysed blinded to the intervention status of
participants.
Interim analysis and monitoring by the Data Management
Committee (DMC)
We do not expect any adverse effects of the intervention
but plan to carry out two interim analyses in 2018 and
2019, which will be reported to an independent Data
Management Committee (DMC) to be convened accor-
ding to the DAMOCLES charter [44]. For these meet-
ings, the DMC will be provided with a report on the two
key safety measures for the trial, presented separately by
trial arm. The two key safety measures are infant and
maternal mortality. The DMC will decide at each mee-
ting whether to request further analyses, which may
include analysis of the study primary outcomes, and will
on each occasion recommend the study should either
continue or stop. The DMC may also comment on
whether any changes to the trial should be made, for
example if the basis of the sample size calculation is
contradicted by the accumulating data or if changes are
required to improve recruitment or data capture. Only
the trial statistician and the DMC will be aware of the
outcomes on these safety measures.
Final analysis
Final analyses will be by intention-to-treat, based on all
enrolled mothers who were pregnant during the recruit-
ment period (July 2017 to July 2018) and their children,
regardless of whether they received the intervention or
not. We will test for differences in the primary outcomes
between the intervention and control arms using logistic
regression for binary outcomes, and ordinal logistic re-
gression for ordinal outcomes, adjusting for clustering
using random effect models.
Provided there is no qualitative difference between the
odds ratios for the effect of the intervention across the
primary outcomes, then only the summary odds ratio
will also be presented. This will be the primary effect
measure for the trial. It will be estimated using inde-
pendence estimating equations because not all partici-
pants will be eligible for all outcomes (e.g. vaccination of
infants who died) and this approach avoids any implicit
imputation of outcomes for ineligible participants.
Besides the issue of ineligible outcomes described pre-
viously, there should be no completely missing data on
the primary outcomes. If a record of attendance cannot
be found in the patient records in the study area, this
will be interpreted as failure to attend. However, partici-
pants may make visits to facilities outside the study area,
often in relation to temporarily or permanently moving
to reside outside the study area. As described in Section
Collecting data on visits to facilities outside the study
area, data on visits outside the study area will be avai-
lable for all higher-risk participants, and dependent on
telephone interviews also available (though approximate)
for up to half the lower-risk participants.
We plan to conduct our primary analysis based only
on data on lower-risk participants from visits within
the study area if it seems this will not lead to bias,
but to use the approximate number of visits outside
the study area from (up to) half the lower-risk partici-
pants to impute these additional visit data for the
remaining participants if it seems bias will otherwise
arise. We prefer not to impute visits out of the study
area unless this is required because the data on visits
outside the area by lower-risk participants are only
approximate.
The precise criteria by which will we judge if bias is
likely, and exactly how imputation will be conducted if
necessary, will be specified in our analysis plan. If imput-
ation is conducted then the analysis based on imputed
data will be considered primary.
In our primary analysis we will adjust for key predic-
tors of the primary outcomes, and any other baseline
factors of clusters or individual participants for which an
important imbalance is seen between arms. We will also
carry out sub-group analyses to examine whether the
effect of the intervention differs by wealth/multi-dimen-
sional poverty quintile to understand the equity impact
of the intervention.
The final analysis will be presented according to the
consolidated standards of reporting trials (CONSORT)
requirements for cRCTs [45, 46]. Both the interim
and final analyses will be conducted by the trial
statisticians. A detailed statistical analysis plan will be
prepared and finalized in consultation with the Trial
Steering Committee (TSC)/DMC before analysis
begins.
Discussion
The ongoing intervention seeks to positively impact
maternal and child healthcare-seeking in one of the
poorest provinces in Kenya, improving survival and
reducing morbidity among the most vulnerable. It
aims to achieve this by enhancing the demand for
continuity of care from the antenatal period through
to the postnatal and early life period, thereby maxi-
mising the gains obtained from each stage in these
processes. Being amongst the first rigorous evalua-
tions of maternal health incentive payments in East
Africa, it will generate results of great policy interest
for the region and sub-Saharan Africa as a whole. In
addition to providing evidence on the role of
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conditional cash transfers in encouraging uptake of
maternal and child healthcare visits, it will also pro-
vide evidence on the benefit of an extended con-
tinuum of care on child survival and maternal health.
Both a strength and limitation of this trial design is
the reliance on functioning technical systems to track
health service use and make the cash transfers. In the
rural Kenyan context, electricity provision may be unre-
liable and mobile phone coverage inconsistent. This may
pose a risk to trial protocol adherence and manual
back-up systems have been devised in the event of tech-
nical failure. A further limitation of the design is the fol-
low up of a limited sub-sample of participants for the
telephone interviews. While this is the most pragmatic
and cost-effective design for the trial, a larger sample
size would provide us with greater power to detect
smaller effects.
It is further acknowledged, that this study addresses
only the demand-side factors that negatively affect
timely and repeated care-seeking in this context.
Supply-side factors affecting care-seeking and health
outcomes may reduce the observed effectiveness of the
intervention. For example, it is well-documented that
poor service quality and negative staff attitudes are also
among the factors that keep women away from the
health facilities [10]. The process evaluation previously
described will assist in measuring the likely effect of
supply-side factors on trial outcomes. Similarly, patient
perceptions of quality of care will be collected during
the telephone interviews. In addition, a sample of key
informant interviews will be conducted with healthcare
providers to explore provider perceptions of quality of
care since the introduction of the scheme and their per-
ception of whether the “carrying capacity” of their insti-
tution is being exceeded. It is likely however, that this
will remain an area for future study.
Trial status
The trial is ongoing. Recruitment began on 15 July
2017 and ended on 31 July 2018. Protocol Version 2.1,
26 December 2018.
Endnotes
1The health records are maintained in a book whereby
all the details of an individual are filled in one row in
the data book, while the columns contain the data fields.
In one of the blank columns, the nurse will add a re-
movable sticker that contains the ID of each participant
at enrolment (during the pilot they used a different pen
colour for research participants; however, this is perman-
ent and therefore not appropriate as the records have
multiple uses). At the time of data extraction, a nurse
will place a removable sticker on the column that
contains the names of the participants, thereby conceal-
ing those names from the staff extracting the records.
Participant ID numbers will however remain. The re-
cords will be extracted in clinic by taking a picture of
the page on the book. Subsequent input of these data is
described in see (Manual extraction of health records).
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